Third Harmonic Bio Stock (NASDAQ: THRD) stock price, news, charts, stock research, profile.
Open | $9.485 |
Close | $9.440 |
Volume / Avg. | 541.249K / 118.268K |
Day Range | 9.025 - 9.660 |
52 Wk Range | 4.030 - 11.600 |
Market Cap | $369.318M |
P/E Ratio | 12.447 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 3.62% |
Days to Cover | 4.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Third Harmonic Bio (NASDAQ: THRD) through any online brokerage.
Other companies in Third Harmonic Bio’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Morgan Stanley on Friday, August 11, 2023. The analyst firm set a price target for 7.00 expecting THRD to fall to within 12 months (a possible -23.50% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Third Harmonic Bio (NASDAQ: THRD) is $9.15 last updated March 28, 2024 at 4:05 PM EDT.
A quarterly cash dividend of $0.12 per share of Class A Common Stock. The quarterly cash dividend was payable on August 15, 2014 to stockholders of record on August 6, 2014.
Third Harmonic Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Third Harmonic Bio.
Third Harmonic Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.